What is ZYBT's relative strength rating?

ZYBT ranks at the 62th percentile over 1 month against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is ZYBT in?

ZYBT is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is ZYBT in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). ZYBT benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is ZYBT?

ZYBT currently shows a 20-day average daily range (ADR%) of 9.5%. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does ZYBT have a seasonal pattern?

TickerStance computes ZYBT's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what ZYBT has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did ZYBT last report earnings?

No SEC EDGAR filings are linked to ZYBT in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Zhengye Biotechnology Holding Limited Class A Ordinary...

TODAY'S READ · AS OF 2026-09-10

As of 2026-09-10, Zhengye Biotechnology Holding Limited Class A Ordinary Shares (ZYBT) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 15.8 (Defensive). Sector: Healthcare, ranked 3 of 11. Average daily range 9.5%, relative volume 0.27×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month—pctile

6 month—pctile

1 year—pctile

Classic—IBD pctile

LDR—leadership

0 of 5 lenses lit · avg RS pctile —

✓ADR%9.5%!A/D—!RVOL0.27×!$ Vol—

Market backdrop

15.8Defensive

Trend30% weight37.5 Breadth30% weight28.1 Leadership20% weight12.8 Macro20% weight53.2 Full stance breakdown →

§ Seasonality

10y · since 2025

Best monthAug on averageavg +49.67% · 100% win · n 2

Worst monthSep on averageavg -72.01% · 0% win · n 1

ZYBT monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	ZYBT Jan avg: -10.24% median: -10.24% win: 0% σ: 6.63% n: 2 2025-01-08 → 2026-08-31	ZYBT Feb avg: -13.25% median: -13.25% win: 0% σ: 7.03% n: 2 2025-01-08 → 2026-08-31	ZYBT Mar avg: 22.32% median: 22.32% win: 100% σ: 7.74% n: 2 2025-01-08 → 2026-08-31	ZYBT Apr avg: 33.87% median: 33.87% win: 50% σ: 50.14% n: 2 2025-01-08 → 2026-08-31	ZYBT May avg: -4.29% median: -4.29% win: 0% σ: 4.67% n: 2 2025-01-08 → 2026-08-31	ZYBT Jun avg: -27.09% median: -27.09% win: 0% σ: 9.51% n: 2 2025-01-08 → 2026-08-31	ZYBT Jul avg: 44.53% median: 44.53% win: 50% σ: 73.39% n: 2 2025-01-08 → 2026-08-31	ZYBT Aug avg: 49.67% median: 49.67% win: 100% σ: 27.71% n: 2 2025-01-08 → 2026-08-31	ZYBT Sep avg: -72.01% median: -72.01% win: 0% σ: 0.00% n: 1 2025-01-08 → 2026-08-31 (current)	ZYBT Oct avg: -6.11% median: -6.11% win: 0% σ: 0.00% n: 1 2025-01-08 → 2026-08-31	ZYBT Nov avg: -15.04% median: -15.04% win: 0% σ: 0.00% n: 1 2025-01-08 → 2026-08-31	ZYBT Dec avg: -44.98% median: -44.98% win: 0% σ: 0.00% n: 1 2025-01-08 → 2026-08-31

Evidence · 1 of 3

Receipts behind the read

0 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

62

3m

—

6m

—

1y

—

LDR

—

StageWeinstein stage analysis

Stage 4 · Decline

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

Fundamentals · ZYBT

Does the business back the chart?

No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

CYPH
99RS 3m
HELP
99RS 3m
NXTC
99RS 3m

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials73

Materials64

Industrials

Public attention · ZYBT

Is the crowd watching?

27/ 100 · vs its own 90-day norm▲ 4 vs 7d

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

Reference

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2834

Float9.2Mshares

Shares out47.4Mshares

Market cap$75.4MMicro Cap

FAQ

Frequently asked questions

What is ZYBT's relative strength rating?: ZYBT ranks at the 62th percentile over 1 month against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is ZYBT in?: ZYBT is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is ZYBT in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). ZYBT benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is ZYBT?: ZYBT currently shows a 20-day average daily range (ADR%) of 9.5%. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does ZYBT have a seasonal pattern?: TickerStance computes ZYBT's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what ZYBT has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

Zhengye Biotechnology Holding Limited Class A Ordinary Shares (ZYBT) — Stance & relative strength

Lenses lit

Market backdrop

§ Seasonality

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

§ Seasonality

Zhengye Biotechnology Holding Limited Class A Ordinary Shares (ZYBT) — Stance & relative strength

ZYBT is not confirmed as a leader. 3m RS is unavailable, Market Stance is 15.8

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?